Designation of eligible bioequivalence testing centers eyed

The government plans to make public its revised guideline over the designation of eligible bioequivalence testing centers as part of efforts to prevent any false testing results, according to the Korea Food and Drug Administration.

In an information session on December 17, a KFDA official Kim Ho-jung said that the KFDA will soon publish a detailed guideline on such designation, including req...